Dr. Aaron Rollins
Dr. Aaron Rollins is our founder and Executive Chairman of our Board of Directors. Dr. Rollins previously served as our Chief Executive Officer from 2012 to 2023. He is the cosmetic surgeon to the stars as well as the founder of Elite Body Sculpture. Dr. Rollins is considered a specialist in body sculpting and has performed thousands of laser liposuction procedures. He is a life-long art lover who studied sculpture and to fulfill his dream of combining art and science, he eventually attended medical school. Dr. Rollins went to medical school at the McGill University Faculty of Medicine in Montreal, Canada after completing his undergraduate studies at McGill University. He has received many awards for his distinguished work, including the I.D.E.A. Bronze Medal for medical inventions and the “Great Distinction” honor at McGill University. He is an affiliate member of the American College of Surgeons, and a diplomate certificate holder in the American Board of Laser Surgery. He is also a physician member of the American Academy of Cosmetic Surgery and the American Society of Liposuction Surgery – a subspecialty group under the auspices of the AACS – and a member of the World Academy of Cosmetic Surgery. He is also a member of the World Academy of Cosmetic Surgery. Dr. Rollins was awarded the Compassionate Doctor certification in 2013.
Chief Executive Officer
Todd Magazine has served as our Chief Executive Officer since January 23, 2023. Mr. Magazine brings to AirSculpt more than 30 years of experience in retail operations and brand-building. Prior to joining the company, he served as the CEO of Blink Fitness, a subsidiary of Equinox, for 10 years in which he led the company of over 1,500 employees from four locations to over 100 and increased membership 25x. Previously, he was North American President of Pfizer's OTC business, held president's roles for Gatorade and Quaker Oats at PepsiCo, and led various marketing teams at Procter & Gamble. Mr. Magazine received a BA from The University of Michigan and his MBA from Northwestern University's Kellogg School of Management.
Adam Feinstein is the non-executive Chairman of our Board of Directors. He founded Vesey Street Capital Partners, L.L.C. (VSCP) in 2014 and has 25 years of experience working with many of the leading healthcare services companies. He is currently Chairman of the Board of Directors of HealthChannels, a provider of medical scribe support and value-based healthcare solutions, and Quality Metric, a provider of health and disease specific surveys. He also serves as a member of the Board of Directors of Pathgroup, a leading pathology services company. Prior to founding VSCP, Mr. Feinstein was the Senior Vice President of Corporate Development, Strategic Planning and Office of the Chief Executive Officer at LabCorp. Prior to LabCorp, Mr. Feinstein served as the Managing Director in Equity Research at Barclays Capital/Lehman Brothers and was ranked #1 in the Institutional Investor All America Research Survey in the Health Care Facilities category for eight years. Mr. Feinstein is a CFA Charterholder and holds a B.S. in Business from the Smith School at the University of Maryland.
Daniel Sollof has served as a member of our board of directors since October 2018. Mr. Sollof joined VSCP in August 2014 and serves as a General Partner for the firm. In addition to sourcing and evaluating potential investment opportunities, Mr. Sollof works closely with VSCP’s portfolio companies. He has been a Board Observer at HealthChannels (ScribeAmerica) since October 2016. From July 2015 to August 2017, he served as a member of the Board of Directors of Imedex, Inc. Prior to joining VSCP, Mr. Sollof served as Vice President and Research Analyst for Barclays Capital/Lehman Brothers August 2007 to August 2014,focusing on the Healthcare Facilities and Medical Supplies & Devices Sectors. Prior to Barclays Capital/Lehman Brothers, Mr. Sollof worked as a Valuation and Business Modeling Analyst in the Transaction Advisory Services group at Ernst & Young from September 2005 to July 2007. Mr. Sollof received a B.S. in Management Science from the University of California – San Diego and is a CFA charterholder.
Caroline Chu has served as a member of our board of directors since September 2021. Prior to joining the Company, Ms. Chu served as Managing Director for Alwyne Management LP from May 2018 to January 2020. Ms. Chu also served as Investment Analyst, Portfolio Manager, and Managing Director for the Goldman Sachs Group, Inc. from June 2002 to February 2018. Ms. Chu received her B.S. in Economics and Management Science from the Massachusetts Institute of Technology.
Thomas Aaron has served as a member of our board of directors since September 2021. Mr. Aaron joined Cincinnati Financial Corporation (Nasdaq: CINF) in November 2019 and currently serves as a member of the Board of Directors, as a member of CINF’s Audit Committee, and as a member of the Boards of Directors of CINF’s property casualty insurance companies and other subsidiaries. From 2016 to 2017, Mr. Aaron served as Senior Vice President of Finance of Community Health Systems, Inc. (NYSE: CYH). Mr. Aaron was appointed to serve as Executive Vice President and Chief Financial Officer of CYH in May 2017, a position in which he served through December 2019. Prior to joining CYH, Mr. Aaron had a distinguished, 32-year career at Deloitte leading audit and consulting services to national healthcare organizations. Mr. Aaron is a Certified Public Accountant and holds a B.S. in Accounting from University of Kentucky.
Kenneth Higgins will become a member of our board of directors upon consummation of this offering. Mr. Higgins currently serves as the managing director and co-founder of Northborne Partners, LLC, a middle market-focused mergers and acquisitions advisory firm. Previously, Mr. Higgins spent 4.5 years at BMO Capital Markets Corp. (a subsidiary of Bank of Montreal (NYSE: BMO)) from 2016 to 2021. Mr. Higgins received his Bachelor of Business Administration from the University of Michigan School of Business and his Juris Doctor degree from Harvard Law School.
Ms. Netzky co-founded Skinny Pop Popcorn in 2010 and served as its President until July 2014. In 2014, SkinnyPop Popcorn sold a majority stake to TA Associates, a leading private equity firm, and changed its name to Amplify Snack Brands. Ms. Netzky transitioned to become a Senior Advisor of Amplify Snack Brands in 2014 and was named a board member of the company. In 2015, Amplify Snack Brands went public on the New York Stock Exchange (formerly NYSE: BETR). Ms. Netzky continued to serve on the board of directors until its sale to The Hershey Company (NYSE: HSY) in 2018 in a transaction valued at approximately $1.6 billion. Ms. Netzky has shown dedicated support to the City of Chicago as well as the arts, education and health care. She has been recognized for her philanthropic pursuits by The Illinois Holocaust Museum. Ms. Netzky earned a BA from DePaul University.
Board Diversity Matrix
Based upon voluntary self-identification by each member of our Board of Directors, the table below sets forth the diversity composition of our Board of Directors as of October 20, 2022. Each of the categories listed in the table below has the meaning set forth in Nasdaq Rule 5605(f).
|Total Number of Directors||8|
|Part I: Gender Identity||Female||Male|
|Part II: Demographic Background|